“…We hypothesized that α-hederin might regulate A549T-derived sEVs cargos involved in TGFβ/SMADs and SREBF1/FASN signaling. A variety of non-coding RNAs, including microRNAs (miR-21-5p, miR-23a-3p, miR-125b-5p, miR-145-5p, miR-26a-5p, miR-6766-3p, miR-671-5p, let-7a-5p, miR-486-5p, miR-29c-3p, and miR-29c-5p) and long non-coding RNAs (lncRNA ZEB1-AS1, LINC00960, LINC02470, lncRNA SOX2-OT, and lncRNA CDKN2B-AS1), were shown to be sorted into sEVs or exosomes and directly targeted regulatory genes in the TGFβ/SMADs pathway ( Solé et al, 2015 ; Fang et al, 2016 ; Hu et al, 2019a ; Huang et al, 2020 ; Wang et al, 2021b ; Chen et al, 2021 ; Wang et al, 2021c ; Lin et al, 2021 ; Wu et al, 2021 ; Zhou et al, 2021 ; Wu et al, 2022a ; Luo et al, 2022 ). Among these non-coding RNAs, we observed that miR-21-5p, miR-23a-3p, and miR-125b-5p decreased after treatment with A549T-derived sEVs and increased after further treatment with α-hederin ( Figure 6A ).…”